Evercrisp Biosciences, Inc. — Form D
Evercrisp Biosciences, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2021-08-25. The offering totals $75.0M, of which $3.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-08-25
- Form: D
- Accession: 0001880233-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $75.0M
- Amount sold: $3.5M
- Remaining: $71.5M
- Investors: 1
- Date of first sale: 2021-08-11
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-411281
Issuer
- Name: Evercrisp Biosciences, Inc.
- CIK: 0001880233
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 230 PARK AVENUE, NEW YORK, NY, 10169
- Phone: 781-367-5419
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Anna Batarina | Director | Larkspur, CA |
| Seth Harrison | Director | Redwood City, CA |
| Tanja Kortemme | Director | New York, NY |
| Spiros Liras | Director | New York, NY |
| Spiros Liras | Executive Officer | New York, NY |
More